Diabetes is currently one of the fastest growing non-communicable diseases globally. According to the International Diabetes Federation (IDF), in 2021 the world had about 537 million adults with diabetes and this number is expected to increase to 643 million by 2030.
The disease not only affects blood sugar control but also increases the risk of cardiovascular, kidney, neurological, diabetic foot and many other metabolic disorders complications.
Speaking at the opening of the conference, Dr. Nguyen Phi Hung - Medical Director of Hoan My Cuu Long Hospital said that diabetes is no longer a simple disease of blood sugar disorders but needs to be approached from a comprehensive management perspective, aiming to protect multiple organs and prevent long-term complications.
Dr. Nguyen Phi Hung clearly stated that this conference is an opportunity for experts and medical staff to update the latest advances in the field of Endocrinology - Metabolism, and at the same time share practical experiences to improve the quality of patient care in the Mekong Delta region.
The conference gathered many prestigious experts from Cho Ray Hospital, 115 People's Hospital, Ho Chi Minh City University of Medicine and Pharmacy, Can Tho City Heart Hospital, Can Tho Central General Hospital, Hoan My Cuu Long Hospital and many medical facilities inside and outside the region.
Scientific topics focus on issues of concern in current clinical practice, such as updating recommendations from the American Diabetes Association (ADA) in 2026, the role of new treatment therapies in the management of type 2 diabetes, strategies to optimize insulin treatment, combination of hypoglycemic drugs, post-feeding blood sugar control as well as solutions to protect cardiovascular, kidney and metabolic health for diabetic patients.
Notably, the conference dedicated a specialized session to comprehensive management of diabetic foot complications. Experts updated new advances in diabetic foot care, post-hospital management strategies, application of negative pressure aspiration therapy in wound treatment and multi-specialized care models to reduce the risk of severe complications, preserve limbs and improve the quality of life for patients.
In addition, the conference also updated modern treatment trends according to ADA 2026 recommendations, which emphasizes the role of drug groups that bring cardiovascular - kidney - metabolic benefits, multi-organ protection strategies and weight control in people with type 2 diabetes.
Within the framework of the program, BS.CKII. Thach Thi Phola - Head of Department of Endocrinology, Internal Neurology, Hoan My Cuu Long Hospital, presented the topic "Updating ADA 2026 - New approach in comprehensive management of 2nd type diabetes patients with Semaglutide".
According to BS.CKII. Thach Thi Phola, the current trend in diabetes treatment is not only focused on controlling blood sugar but also towards comprehensive patient management, including weight control, protecting cardiovascular, kidney and target organs to reduce the risk of long-term complications.
Individualizing treatment based on the characteristics of each patient is becoming one of the important principles to optimize treatment effectiveness and improve long-term prognosis.
